A carregar...

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

MYCN amplification is a major biomarker of poor prognosis, occurring in 25-30% of neuroblastomas. MYCN plays contradictory roles in promoting cell growth and sensitizing cells to apoptosis. We have recently shown that p53 is a direct transcriptional target of MYCN in neuroblastoma and that p53-media...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gamble, Laura D., Kees, Ursula R., Tweddle, Deborah A., Lunec, John
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191119/
https://ncbi.nlm.nih.gov/pubmed/21725357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!